Search for Genetic Modifiers of PSC: Time to Increase the Number of Needles in the Haystack
Journal Title: Annals of Hepatology - Year 2017, Vol 16, Issue 6
Abstract
Primary sclerosing cholangitis (PSC) belongs to the most obscure liver diseases. Patients with progressive PSC require liver transplantation as only therapeutic option. Previously several HLA- and non-HLA-associated PSC risk variants have been discovered, however their involvement in the development of PSC seems to be minor in comparison to environmental determinants. Lately, variant rs853974 at the RSPO3 gene locus has been shown to modulate the course of PSC. Here we briefly discuss the phenotypes related to this polymorphism and propose alternative directions of research that might help to identify new genetic modifiers of PSC progression.
Authors and Affiliations
Marcin Krawczyk, Frank Lammert
Keywords
Related Articles
- EP ID EP227993
- DOI 10.5604/01.3001.0010.5271
- Views 99
- Downloads 0
Molecular and serological characterization of occult hepatitis B infection in blood donors from Mexico
Occult hepatitis B virus (HBV) infection (OBI) is characterized by presence of HBV DNA in blood or liver tissue without detectable HBV surface antigen (HBsAg), with or without antibodies to hepatitis B core antigen (anti...
Noninvasive markers of fibrosis: key concepts for improving accuracy in daily clinical practice
Noninvasive markers of fibrosis have emerged as an alternative to the staging of fibrosis by means of liver biopsy. Apart from being noninvasive and thus lacking the adverse effects of liver biopsy, they offer some adva...
Serum cystatin C: a non-invasive marker of liver fibrosis or of current liver fibrogenesis in chronic hepatitis C?
Background. Serum levels of cystatin C, an endogenous inhibitor of cysteine proteases, provide an alternative method to creatinine-based criteria for measuring glomerular filtration rate. Preliminary data suggested that...
Conversion to mycophenolate mofetil monotherapy in liver recipients: Calcineurin inhibitor levels are key
The use of calcineurin inhibitors (CNI) after liver transplantation is associated with post-transplant nephrotoxicity. Conversion to mycophenolate mofetil (MMF) monotherapy improves renal function, but is related to gra...
Angiogenesis in chronic liver disease
Background: Chronic liver disease is characterized by inflammation and fibrosis. As a consequence angiogenesis leading to new vasculature may have prognostic value in disease progression. Interfering with angiogenesis ma...